JN-11002 Monkeypox Virus Nucleic Acid Detection Kit (Fluorescent PCR Method)

Project Overview: This kit is used for the qualitative detection of the F3L gene of the monkeypox virus in serum, lesion exudates, or respiratory swab samples (oropharyngeal and nasopharyngeal swabs) from suspected monkeypox cases or other individuals requiring diagnosis or differential diagnosis of monkeypox virus infection.
 
Product Purpose: This kit is used for the qualitative detection of the F3L gene of the monkeypox virus in serum, lesion exudates, or respiratory swab samples (oropharyngeal and nasopharyngeal swabs) from suspected monkeypox cases or other individuals requiring diagnosis or differential diagnosis of monkeypox virus infection.
 
Product Information: Packaging Specifications: 24 tests/box, 100 tests/box
 
Sample Requirements:
Serum Samples: Use a disposable sterile sampling tube to draw 3-4mL of venous blood from the subject's arm, let it stand at room temperature for about 30 minutes (not exceeding 60 minutes) until the serum separates naturally, then transfer it to a 1.5mL sterile centrifuge tube for use.
Skin Lesion Samples: Including swabs of the surface and/or exudate of lesion rashes, vesicles, vesicular fluid, vesicular epidermis, or scabs. Use a disposable polyester fiber swab to repeatedly rub the lesion to ensure sufficient viral DNA is collected. Place the swab into a disposable viral sampling tube containing viral preservation solution, discard the tail, and tighten the cap.
Respiratory Swab Samples: Including oropharyngeal and nasopharyngeal swab samples. Use a disposable polyester fiber swab to repeatedly rub the posterior part of the uvula, posterior pharyngeal wall, and both tonsils, avoiding contact with the tongue, to collect oropharyngeal swabs; or gently insert a disposable polyester fiber swab into the nasal cavity to the nasal palate, stay for a moment, then slowly rotate and exit to collect nasopharyngeal swabs. Place the collected swabs into a disposable viral sampling tube containing viral preservation solution, discard the tail, and tighten the cap.
Storage and Transport: Collected specimens should be tested promptly. If immediate testing is not possible, store at 2-8°C for up to 3 days; for longer storage, store at -20°C ± 5°C for up to 12 months, or at -70°C for longer preservation. Samples should not be frozen and thawed more than 4 times. Before testing, samples must be brought to room temperature. Frozen samples should be completely thawed, rewarmed, and mixed thoroughly before use.
 
Storage Conditions and Shelf Life: Store at -20°C ± 5°C, with a provisional shelf life of 12 months. Use promptly after opening, and do not freeze and thaw more than 3 times. Discard after more than 3 freeze-thaw cycles. The production date and expiration date are indicated on the label.
 
Application Scenarios and Downstream Customers
Application Scenarios:
Medical Institutions: Hospitals and clinics for the rapid diagnosis of monkeypox virus infections, particularly in outbreak situations.
Public Health Agencies: For monitoring and controlling outbreaks, quickly identifying and isolating infected individuals to prevent the spread of the monkeypox virus.
Research Laboratories: For epidemiological studies and research on the prevalence and impact of the monkeypox virus.
Emergency Response Units: For immediate testing and diagnosis during outbreaks to enable swift medical response and containment.
Travel and Immigration Health Centers: For screening travelers from regions with known monkeypox virus outbreaks.
 
Downstream Customers:
Laboratory Personnel in Hospitals and Clinics
Public Health and Epidemic Prevention Workers
Emergency Response and Disaster Management Teams
Researchers in Epidemiological and Virological Studies
Travel and Immigration Health Officials
 
Business Opportunities and Market Potential Analysis
Business Opportunities in Latin America, Arab Countries, and Africa:
Market Demand:
Latin America: Increasing travel and trade with regions where monkeypox outbreaks have occurred necessitates robust screening and diagnostic capabilities.
Arab Countries: Growing healthcare infrastructure and emphasis on preventing infectious diseases increase demand for advanced diagnostic tools.
Africa: Higher prevalence of zoonotic diseases, including monkeypox, necessitates rapid and accurate detection methods for effective management and control.
Market Potential:
Latin America: Governments and private healthcare providers are investing in modern diagnostic technologies to handle emerging infectious diseases.
Arab Countries: Strong healthcare investments and a focus on infectious disease prevention and control create a substantial market for advanced diagnostic kits.
Africa: International health organizations and local governments are focused on improving healthcare infrastructure and disease management capabilities.
 
Resource and Condition Recommendations for Distributing This Product:
Resource Conditions:
Logistics Network: Reliable cold chain logistics system to ensure product transportation and storage at appropriate temperatures.
Marketing: Effective marketing and promotional strategies to increase product awareness and educate potential customers about the benefits of rapid and accurate monkeypox virus detection.
After-Sales Service: Providing technical support and training to ensure correct product usage and maximize customer satisfaction.
Recommended Conditions:
Infrastructure: Suitable warehousing and distribution capabilities to handle the product's storage and delivery requirements.
Partnerships: Establishing good relationships with local medical institutions, public health departments, and research laboratories to facilitate product adoption and market penetration.
Sales Network: Having a wide customer base and sales channels to effectively reach and serve potential customers.
Primary Customer Targets:
Medical Institutions: Local hospitals, clinics, and laboratories that require rapid and accurate diagnostic tools for monkeypox virus infections.
Public Health Departments: Local and national public health and epidemic prevention agencies responsible for monitoring and controlling infectious diseases.
Research Laboratories: Institutions conducting epidemiological and virological research on the monkeypox virus.
Emergency Response Units: Organizations involved in disaster management and immediate medical response during outbreaks.
Travel and Immigration Health Centers: Facilities responsible for screening travelers and managing health risks associated with international travel.